About Herbs, Botanicals & Other Products

Scientific Name
Hydrastis canadensis
Common Name

Eye root, yellow Indian plant, turmeric root, yellow paint root, orange root, goldenroot

Clinical Summary

Derived from the root of the plant, goldenseal is though to have anti-inflammatory and antimicrobial activities. It is used by patients to treat a variety of ailments including common cold, fever, infections, heart conditions, constipation, and muscle spasms. Primary active components are hydrastine, berberine, and canadine. An in vitro study found that of all the herbs studied, an extract from Hydrastis canadensis was one of the most active in inhibiting the growth of H. pylori (1). Studies done on berberine indicate that it has antimicrobial property and also inhibit growth and induces apoptosis in certain cancer cells (2) (3) (4) (5) (6). No clinical studies evaluating its efficacy have been published.

Minimal adverse events have been reported at recommended doses, but nausea, vomiting, hallucinations, or seizures may be signs of toxicity (7). Potential drug interactions include reduced effect of anticoagulants, altered response to antihypertensives, and inhibition of cytochrome P (CYP) 450 3A4 (8) (9) (10) and CYP2D6 (11). Goldenseal supplementation did not affect P-Glycoprotein activity in vivo (12). One case of hypernatremia, which may have been induced by goldenseal supplementation, was reported in a patient with diabetic ketoacidosis (13). Patients with hypertension, cardiovascular disease, or are pregnant should not take this herb.

Purported Uses
  • Anorexia
  • Cancer treatment
  • Cirrhosis
  • Colitis
  • Common cold
  • Conjunctivitis
  • Diabetes
  • Edema
  • Fever
  • Infections
  • Menorrhagia
Constituents
  • Alkaloids: Hydrastine (1.5-4%), berberine (0.5- 6%), canadine, beta-hydrastine, canadaline
    (1)
Mechanism of Action

Goldenseal is claimed to have anti-inflammatory, astringent, antimicrobial, and laxative properties (8). The pharmacological action of goldenseal is attributed to both hydrastine and berberine. The majority of clinical studies were not performed with goldenseal, but rather on berberine and hydrastine. Berberine has anti-microbial activity against certain pathogens such enterotoxigenic E. coli and V. cholera. It also induces cell cycle arrest and apoptosis in a variety of cancer cell lines (2) (15) (16). One in vitro study found that berberine inhibited the growth of adherent and anoikis resistant MCF-7 and MDA-MB-231 breast cancer cells to a greater extent than doxorubicine (4). In one study, berberine alkaloids produced an average of 91% tumor inhibition against 6 malignant brain tumor cell lines both in vivo in mice and in vitro against human brain tumors (5). Berberine alkaloids were also shown to have potent macrophage-activating and cytostatic activity against tumor cells. Another study performed in vitro tests on a series of human malignant brain tumor cells and rat brain tumor cells (6). Berberine used alone at a dose of 150 mcg/ml had an average cancer cell kill rate of 91%. BCNU (carmustine) had a cell kill rate of 43%. Rats treated with berberine at 10 mg/kg had an 81% kill rate. The combination of both berberine and BCNU had additive effects in killing cancer cells. In an animal study, berberine has been shown to prolong QTc interval and to help prevent ventricular fibrillation after myocardial infarction (17). The hydrastine component induces constriction of peripheral blood vessels (13). While two small clinical trials reported that goldenseal affects CYP2D6 (18) and CYP3A (10), another could not confirm such effects (19).

Warnings

Berberine-containing botanicals may cause QTc prolongation in patients with severe underlying heart disease.

Contraindications

Patients who have hypertension or cardiovascular disease or women that are pregnant or nursing should not consume goldenseal.

Adverse Reactions

Common: GI complaints
Rare: Nervousness
Toxicity: Stomach ulcerations, constipation, convulsions, hallucinations, nausea, vomiting, depression, nervousness, bradycardia, respiratory depression, seizures (1)

Herb-Drug Interactions

Antihypertensives: Goldenseal may interfere with blood pressure control.
Anticoagulants / Antiplatelets: Berberine may inhibit anticoagulant effects.
Barbiturates: Goldenseal may potentiate effects.
Cytochrome P-450: Goldenseal may inhibit the CYP3A4 and CYP2D6 isoenzymes, resulting in increased levels of certain medications such as cyclosporine A (16).
Vitamin B Complex: Goldenseal may decrease gastric absorption resulting in possible deficiency.

Herb Lab Interactions

Berberine may increase bilirubin levels due to displacement of bilirubin from albumin (21).
Goldenseal may cause a darkening in urine color in illicit drug testing (22).
Goldenseal may alter PT / PTT / INR anticoagulation test results (8).
May prolong QTc interval in electrocardiogram (17).
One case of hypernatremia was reported in a patient with diabetic ketoacidosis (13).

References
  1. Cwikla C, Schmidt K, Matthias A, et al. Investigations into the antibacterial activities of phytotherapeutics against Heliobacter pylori and Campylobacter jejuni. Phytotherapy Research. 2010;24:649-656.
  2. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. Feb 2006;5(2):296-308.
  3. Rabbani G, et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and vibrio cholerae. J Infect Dis 1987;155:979-84.
  4. Kim JB, Yu JH, Ko E, et al. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine. 2010 May;17(6):436-40.
  5. Werbach MR, et al. Botanical Influences on Illness: A Sourcebook of Clinical Research. Tarzana, California: Third Line Press; 1994.
  6. Zhang RX, et al. Laboratory studies of berberine use alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chin Med J 1990;103:658-65 PMID: 2122945
  7. Barnes J, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press; 1996.
  8. Budzinski JW, et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82.
  9. Chatterjee P,.Franklin MR. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos. 2003;31:1391-7.
  10. Gurley BJ, Swain A, Hubbard MA, et al. Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clin Pharmacol Ther. Jan 2008;83(1):61-69.
  11. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77(5):415-26.
  12. Gurley BJ, Swain A, Barone GW, et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2007;35(2):240-5.
  13. Bhowmick SK, Hundley OT, Rettig KR. Severe hypernatremia and hyperosmolality exacerbated by an herbal preparation in a patient with diabetic ketoacidosis. Clin Pediatr (Phila). Nov 2007;46(9):831-834.
  14. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal medicines. 2nd ed. Montvale (NJ): Medical Economics Company; 1998.
  15. Jantova S, Cipak L, Letasiova S. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol In Vitro. Feb 2007;21(1):25-31.
  16. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol. May 2008;61(6):1007-1018.
  17. Xu Z, Cao HY, Li Q. [Protective effects of berberine on spontaneous ventricular fibrillation in dogs after myocardial infarction]. Zhongguo Yao Li Xue Bao. Jul 1989;10(4):320-324.
  18. Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John’s wort, and Echinacea. Mol Nutr Food Res. Jul 2008;52(7):755-763.
  19. Sandhu RS, Prescilla RP, Simonelli TM, Edwards DJ. Influence of goldenseal root on the pharmacokinetics of indinavir. J Clin Pharmacol. 2003;43:1283-8.
  20. Wu X, Li Q, Xin H, Yu A, Zhong M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. Sep 2005;61(8):567-572.
  21. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993;63(4):201-208.
  22. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem 1988; 34:2333-6.
How It Works

Bottom Line: The active compound in goldenseal is berberine, which was found helpful in certain conditions. But there is no proof that goldenseal can be used to treat cancer in humans.

The two compounds in goldenseal, berberine and hydrastine, have been studied widely. In animal studies, berberine was found to lower fevers, kill bacteria, fungi and protozoa, and slow the growth of tumors. It also stimulated contractions of the uterus, increased blood flow to the heart, and blocked some molecules involved in inflammation. In human research, berberine treated acute diarrhea, probably because of its antibacterial properties, and improved chronic gall bladder inflammation and liver cirrhosis. Hydrastine was found to constrict blood vessels in the arms and legs. Although an extract of goldenseal caused muscle relaxation in animal tissues, berberine and hydrastine are also known to simulate contraction of the uterus smooth muscles.

Purported Uses
  • To control muscle spasms
    Laboratory studies in animal tissues support this use, but no clinical trials have been performed to confirm that this effect occurs in humans.
  • To treat cancer
    Laboratory studies show that berberine, a compound in goldenseal, inhibits the growth of a variety of tumors in rats, but no clinical trials have been performed.
  • To stimulate the heart and increase blood pressure
    Laboratory studies show that berberine, a compound in goldenseal, stimulates the heart and increases blood flow to it, but results concerning blood pressure are mixed. Clinical trials that confirm this effect have not been conducted.
  • To treat cirrhosis of the liver
    Two clinical trials show that berberine, a compound in goldenseal, improves the condition of patients with cirrhosis.
  • To treat gastrointestinal disorders
    Laboratory studies show that a goldenseal extract causes relaxation of smooth muscle like that found in the gastrointestinal tract, but it is not known if goldenseal helps treat gastrointestinal disorders. No clinical trials have been conducted in humans to confirm this effect.
  • To treat conjunctivitis
    Laboratory data shows that berberine, a compound in goldenseal, has antibacterial properties, but no clinical trials have been conducted to study this effect humans.
  • To treat diabetes
    Two small clinical studies showed that berberine, a compound found in goldenseal, lowers blood glucose levels in type 2 diabetics.
  • To manage painful and heavy menstruation
    Laboratory evidence regarding goldenseal’s ability to relax uterus muscle is mixed. No clinical trials have been performed in humans.
  • To treat infections topically
    Laboratory studies show that berberine, a compound in goldenseal, has wide antibacterial and antifungal properties, but no clinical trials have been performed to confirm that this effect occurs in humans.
  • To lower fevers
    Laboratory studies support this use, but no clinical trials have been performed.
  • To reduce swelling and edema
    Laboratory studies show that berberine, a compound in goldenseal, blocks some of the molecules involved in inflammation. No clinical trials have been performed to confirm that this effect occurs in humans.
Research Evidence

No clinical trials have been conducted with goldenseal.

Patient Warnings
  • This product is regulated by the FDA as a dietary supplement. Unlike approved drugs, supplements are not required to be manufactured under specific standardized conditions. This product may not contain the labeled amount or may be contaminated. In addition, it may not have been tested for safety or effectiveness.
Do Not Take If
  • You have high blood pressure (Goldenseal may increase your blood pressure).
  • You have heart disease (Goldenseal may be a cardiac stimulant).
  • You are pregnant or nursing (Goldenseal may stimulate the muscles of the uterus to contract. Also, it is not known whether the compounds in goldenseal pass into the breast milk).
  • You are taking warfain or other blood thinners (Berberine, a compound found in goldenseal, may lessen their effects).
Side Effects
  • Stomach upset
  • Rarely, nervousness can occur
  • Signs of goldenseal toxicity include stomach ulcers, constipation, convulsions, hallucinations, nausea, vomiting, depression, nervousness, bradycardia (slow heart rate), slowed breathing rate, and seizures.
Dosage (Inside MSKCC Only)
This field is only visible to only Inside MSKCC users.
Aliases
Hydrastis Canadensis
E-mail your questions and comments to aboutherbs@mskcc.org.